Efficacy of entecavir treatment for up to 5 years in patients with HBV-related compensated cirrhosis in Turkey; real life data
(Turk J Gastroenterol 2019; 30: 36-36) DOI: 10.5152/tjg.2019.22
(Turk J Gastroenterol 2019; 30: 36-36) DOI: 10.5152/tjg.2019.22